30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

KYOCERA and KOBE STEEL will integrate their medical material businesses in 9/04. The joint venture, tentatively named JAPAN MEDICAL MATERIALS, will manufacture and market artificial joints and materials based on expertise in ceramics and titanium alloys. For the fiscal year ending 3/31/04, Kyocera and Kobe Steel posted consolidated sales of ¥ 1.14MM and ¥ 1.2MM, respectively. Currently, the Japanese market for artificial joints is valued at ~¥ 73.5 billion (~US $670MM). The new company aims to control a 20% share of this market within 3 years. Japan Medical Materials will conduct business in Japan and the rest of Asia, and will further target regions all over the world. (Kyocera Corporation, 4/28/04)